Skip to content
Sign In

Main Navigation

James Sharp Logo
  • Individuals
    Individuals

    Choose Your Level of Service

    • Discretionary ServiceDiscretionary Service
    • Execution Only ServiceExecution Only Service
  • Charities & Trustees
    Charities & Trustees

    Choose Your Level of Service

    • Discretionary ServiceDiscretionary Service
    • Execution Only ServiceExecution Only Service

  • Companies
    Companies

    Choose Your Level of Service

    • Discretionary ServiceDiscretionary Service
    • Execution Only ServiceExecution Only Service

  • News & Insights
    • News & Insights
    • Current Research Coverage List
  • About Us
    • About Us
    • Our People
  • Conectus Portal
  • Contact Us

Update - Page 83

7 September 2023

Melrose Industries Plc – Half-Year Results 2023

Melrose Industries PLC, an Aerospace Engines and Structures Group, today announces its interim results for the six months ended 30 June 2023 MELROSE INDUSTRIES…

7 September 2023

Mpac Group plc – Half-Year Results

Half Year Results for the six months to 30 June 2023 Mpac Group plc (“Mpac”, “the Company” or “the Group”) Half Year Results for…

7 September 2023

M.P. Evans Group – Acquisition

Acquisition of 8,350 Planted Hectares M. P. EVANS GROUP PLC (“THE GROUP”) ACQUISITION OF 8,350 PLANTED HECTARES M.P. Evans Group PLC, a producer of…

5 September 2023

Advanced Medical Solutions Group plc – Trading Statemenet

Advanced Medical Solutions Group plc (AIM: AMS), the world-leading specialist in tissue-healing technologies, today announces a trading update following recent events that have impacted…

1 September 2023

GSK’s Nucala CRSwNP submission accepted in Japan

GSK’s regulatory submission accepted for review by Japanese regulator for use of Nucala (mepolizumab) in adults with chronic rhinosinusitis with nasal polyps GSK’s regulatory submission accepted…

26 May 2023

Majedie Investments Plc Half Year Report

Majedie Investments PLC Half-Year Financial Report 31 March 2023 Majedie Investments plc (“Majedie” or the “Company”) is pleased to present its Half-Year Financial Report…

17 May 2023

Jersey Electricity plc

Interim Report Jersey Electricity plc Interim Report for the six months ended 31March 2023     The Board approved at a meeting on 17 May 2023 the…

12 May 2023

GSK Plc – MenABCWY vaccine preliminary phase III results

GSK presents pivotal data at ESPID confirming effectiveness of its 5-in-1 meningococcal ABCWY vaccine candidate, with demonstrated coverage against a panel of 110 MenB…

Posts navigation

  • «
  • 1
  • …
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • »

Home > Update > Page 83

James Sharp white Logo
Sign In
Linkedin Icon

The Exchange
5 Bank Street
Bury, Lancashire
BL9 0DN

Tel: 0161 764 4043

Fax: 0161 764 1628

Email: mail@jamessharp.co.uk

Linkedin Icon

James Sharp & Co is a trading name
of James Sharp & Co LLP (0C422665)

Members of the LLP are referred to as Partners

  • Downloads & Resources
  • Complaints
  • Financial Compensation Scheme
  • Conectus Portal

  • Cyber Essentials Certification
  • Website Terms & Conditions
  • Privacy Policy
  • Cookie policy
  • Consent Preferences

Email Newsletter Sign-up

Consent(Required)
What we do with you information. Find out more

© Copyright 2010-2026. All rights reserved. James Sharp & Co. Authorised & Regulated by the Financial Conduct Authority
Member of the London Stock Exchange - Member of the Aquis Stock Exchange - Member of PIMFA

Website by ICG